Relay Therapeutics, Inc. (RLAY) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $410.0K | -79.7% |
| 2024 | $2.02M | -51.1% |
| 2023 | $4.13M | -54.5% |
| 2022 | $9.06M | +161.1% |
| 2021 | $3.47M | +79.8% |
| 2020 | $1.93M | -75.9% |
| 2019 | $8.00M | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $410.0K | -79.7% |
| 2024 | $2.02M | -51.1% |
| 2023 | $4.13M | -54.5% |
| 2022 | $9.06M | +161.1% |
| 2021 | $3.47M | +79.8% |
| 2020 | $1.93M | -75.9% |
| 2019 | $8.00M | — |